default author photo

Carole D. Mitnick

Harvard University - Department of Global Health and Social Medicine

Partners in Health - Partners In Health (Boston)

Harvard University - Division of Global Health Equity

SCHOLARLY PAPERS

4

DOWNLOADS

434

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Bedaquiline, Delamanid, Linezolid and Clofazimine for the Treatment of Rifampicin- and Fluoroquinolone-Resistant Tuberculosis (endTB-Q): A Phase 3, Open-Label, Multicentre, Randomised, Controlled, Stratified, Non-Inferiority Trial

Number of pages: 34 Posted: 06 Apr 2025
IRCSS Sacro Cuore Hospital, - Department of Infectious – Tropical Diseases and Microbiology, Interactive Research and Development Global, Singapore, University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, Epicentre (Paris), Interactive Research and Development (IRD), Karachi, Pakistan, Interactive Research and Development (IRD), Karachi, Pakistan, Interactive Research and Development (IRD), Karachi, Pakistan, National Scientific Center of Phthisiopulmonology, University of Tübingen - Mycobacteriology Unit, Epicentre (Paris), National Scientific Center of Phthisiopulmonology, Médecins Sans Frontières (London), University of Montpellier - Translational Research in HIV and Infectious Diseases (TransVIHMI), Médecins Sans Frontières, Mumbai, India, Médecins Sans Frontières, Geneva, Switzerland, City Center of Phthisiopulmonology, Institute of Tropical Medicine - Mycobacteriology Unit, Hanoi Medical University - Vietnam National Lung Hospital, Médecins Sans Frontières, Geneva, Switzerland, Research Center Borstel, Partners In Health Lesotho, Médecins Sans Frontières, Harvard University - Department of Global Health and Social Medicine, University of Cape Town (UCT) - Division of Clinical Pharmacology, Socios En Salud Sucursal Peru, Institute of Tropical Medicine - Mycobacteriology Unit, The Indus Hospital and Health Network, University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, Hanoi Lung Hospital, Hanoi Medical University - Vietnam National Tuberculosis Programme, Partners In Health Lesotho, University College London - MRC Clinical Trials Unit, Indian Council of Medical Research (ICMR), Indian Council of Medical Research (ICMR) - National AIDS Research Institute, Hanoi Lung Hospital, Pham Ngoc Thach Hospital, University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, University of California, San Francisco (UCSF) - UCSF Center for Tuberculosis, Socios En Salud Sucursal Peru, University of Tübingen - Mycobacteriology Unit, The Indus Hospital and Health Network, Hospital Nacional Sergio E. Bernales, Harvard University - Division of Global Health Equity, Partners In Health Lesotho, Hospital Nacional Hipólito Unanue, Lima, Harvard University - Division of Global Health Equity, Médecins sans Frontières (Paris), Harvard University - Department of Global Health and Social Medicine and Independent
Downloads 189 (401,336)

Abstract:

Loading...

MDR-TB, pre-XDR-TB, multidrug-resistant tuberculosis, pre-extesively drug-resistant tuberculosis, BDLC, personalized medicine, precision medicine, clinical trial, extensive tuberculosis disease, limited tuberculosis disease

2.

Effectiveness and Safety of a Shortened Oral Regimen for Rifampicin- or Multidrug-Resistant Tuberculosis in Peru

Number of pages: 19 Posted: 03 Sep 2025
Hospital Nacional Arzobispo Loayza, Harvard University - Harvard Medical School, Hospital Nacional Hipólito Unanue, Lima, Hospital Nacional Dos de Mayo, Hospital Maria Auxiliadora, Hospital Nacional Arzobispo Loayza, Dirección de Prevención y Control de la Tuberculosis, Instituto Nacional de Salud Pública, Instituto Nacional de Salud Pública, Partners in Health, Harvard University - Harvard Medical School, Socios En Salud, Harvard University - Department of Global Health and Social Medicine, Harvard University - Department of Global Health and Social Medicine, Harvard University - Department of Global Health and Social Medicine, Harvard University - Division of Global Health Equity, Harvard University - Division of Global Health Equity, Harvard University - Department of Global Health and Social Medicine, Harvard University - Department of Global Health and Social Medicine, Harvard University - Department of Global Health and Social Medicine and affiliation not provided to SSRN
Downloads 119 (600,462)

Abstract:

Loading...

TB, culture conversion, quality of life, extensive disease, drug resistance

3.

Safety and Effectiveness of Three Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan

Number of pages: 19 Posted: 01 Feb 2024
Partners In Health Kazakhstan, Harvard University - Department of Global Health and Social Medicine, Harvard University - Department of Global Health and Social Medicine, Atyrau Regional Center of Phthisiopulmonology, Karaganda Regional Center of Phthisiopulmonology, Turkistan Regional Center of Phthisiopulmonology, National Scientific Center of Phthisiopulmonology, Harvard University - Department of Global Health and Social Medicine, Partners In Health Kazakhstan, Harvard University - Department of Global Health and Social Medicine, Partners In Health Kazakhstan, World Health Organization (WHO) - World Health Organization Regional Office for Europe, World Health Organization (WHO) - World Health Organization Regional Office for Europe, Minsk Republican Scientific and Practical Centre of Pulmonology and Tuberculosis, Harvard University - Department of Global Health and Social Medicine, Partners In Health Kazakhstan, Partners In Health Kazakhstan and Harvard University - Division of Global Health Equity
Downloads 93 (725,554)

Abstract:

Loading...

Operational research, shortened treatment, toxicity, bedaquiline, linezolid, levofloxacin

4.

Using Causal Frameworks to Reduce Bias in Observational TB Research: A Comparison of Model-Building Approaches

Number of pages: 25 Posted: 02 Feb 2026
Children's Hospital "Vittore Buzzi", Harvard University - Harvard Medical School, Harvard University - Harvard Medical School, Harvard University - Department of Global Health and Social Medicine, Epicentre (Paris), Interactive Research and Development (IRD) Global, Médecins sans Frontières (Paris), Harvard University - Division of Global Health Equity, Harvard University - Department of Global Health and Social Medicine and London School of Hygiene & Tropical Medicine - Faculty of Infectious and Tropical Diseases
Downloads 33 (1,277,121)

Abstract:

Loading...

MDR/RR-TB, Treatment Outcome, HIV, Observational Studies, Epidemiologic Methods, Causal Inference, Causal Structure